Abstract
Hispanic/Latino ethnicity is associated with improved survival from non-small cell lung cancer compared to that for non-Hispanic Whites even though Hispanics/Latinos are more likely to potentially have inferior access-to-care and experience greater health disparities. To this end, we conducted a literature review to identify possible explanations for this survival benefit, including the role of chronic obstructive pulmonary disease and cardiovascular diseases, genetic variation, cultural influences, and immigration factors. Overall, intermittent smoking patterns, genetic variation, co-morbidities, and cultural influences were all factors likely to partially explain this survival benefit. On the other hand, immigration factors, acculturation, and access-to-care were less likely to support the survival advantage. Future research should analyze relevant Hispanic/Latino subgroups (e.g., Mexican, Puerto Rican, Cuban, Dominican, Central American, South American) and specifically focus on the relationship between Hispanic/Latino ethnicity and different lung cancer subtypes. If the Hispanic/Latino mortality benefit observed in lung cancer truly exists, a better understanding of the underlying mechanism(s) may help extend these benefits to other ethnic and racial groups.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the United States, 1973–2010. PLoS ONE. 2015;10(3):e0121323. https://doi.org/10.1371/journal.pone.0121323.
Cancer of the Lung and Bronchus - Cancer Stat Facts. SEER. https://seer.cancer.gov/statfacts/html/lungb.html. Accessed 16 Aug 2021.
Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162(17):1985–93. https://doi.org/10.1001/archinte.162.17.1985.
Saeed AM, Toonkel R, Glassberg MK, et al. The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer. 2012;118(18):4495–501. https://doi.org/10.1002/cncr.26686.
Patel MI, Schupp CW, Gomez SL, Chang ET, Wakelee HA. How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31(28):3572–8. https://doi.org/10.1200/JCO.2012.48.6217.
Aragones A, Hayes SL, Chen MH, González J, Gany FM. Characterization of the Hispanic or latino population in health research: a systematic review. J Immigr Minor Health. 2014;16(3):429–39. https://doi.org/10.1007/s10903-013-9773-0.
Klugman M, Xue X, Hosgood HD. Race/ethnicity and lung cancer survival in the United States: a meta-analysis. Cancer Causes Control CCC. 2019;30(11):1231–41. https://doi.org/10.1007/s10552-019-01229-4.
Ruiz JM, Steffen P, Smith TB. Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. Am J Public Health. 2013;103(3):e52–60. https://doi.org/10.2105/AJPH.2012.301103.
Price SN, Flores M, Hamann HA, Ruiz JM. Ethnic differences in survival among lung cancer patients: a systematic review. JNCI Cancer Spectr. 2021;5(5). https://doi.org/10.1093/jncics/pkab062
Chen Y, Freedman ND, Rodriquez EJ, et al. Trends in premature deaths among adults in the United States and Latin America. JAMA Netw Open. 2020;3(2):e1921085. https://doi.org/10.1001/jamanetworkopen.2019.21085.
Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ. 1997;315(7114):980–8. https://doi.org/10.1136/bmj.315.7114.980.
Hassmiller KM, Warner KE, Mendez D, Levy DT, Romano E. Nondaily smokers: who are they? Am J Public Health. 2003;93(8):1321–7. https://doi.org/10.2105/AJPH.93.8.1321.
Reyes-Guzman CM, Pfeiffer RM, Lubin J, et al. Determinants of light and intermittent smoking in the United States: results from three pooled National Health Surveys. Cancer Epidemiol Prev Biomark. 2017;26(2):228–39. https://doi.org/10.1158/1055-9965.EPI-16-0028.
Borrayo EA, Scott KL, Drennen AR, Macdonald T, Nguyen J. Determinants of treatment delays among underserved Hispanics with lung and head and neck cancers. Cancer Control. 2016;23(4):390–400. https://doi.org/10.1177/107327481602300410.
Prescott E, Scharling H, Osler M, Schnohr P. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health. 2002;56(9):702–6. https://doi.org/10.1136/jech.56.9.702.
Kaplan RC, Bangdiwala SI, Barnhart JM, et al. Smoking among US Hispanic/Latino adults: the Hispanic Community Health Study/Study of Latinos. Am J Prev Med. 2014;46(5):496–506. https://doi.org/10.1016/j.amepre.2014.01.014.
Klugman M, Hosgood HD, Hua S, et al. A longitudinal analysis of nondaily smokers: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Ann Epidemiol. 2020;49:61–7. https://doi.org/10.1016/j.annepidem.2020.06.007.
Jiang XQ, Mei XD, Feng D. Air pollution and chronic airway diseases: what should people know and do? J Thorac Dis. 2016;8(1):E31-40. https://doi.org/10.3978/j.issn.2072-1439.2015.11.50.
2021 GOLD Reports. Global Initiative for Chronic Obstructive Lung Disease - GOLD. https://goldcopd.org/2021-gold-reports/. Accessed 16 Aug 2021.
Young RP, Hopkins RJ. How the genetics of lung cancer may overlap with COPD. Respirol Carlton Vic. 2011;16(7):1047–55. https://doi.org/10.1111/j.1440-1843.2011.02019.x.
Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–6. https://doi.org/10.1183/09031936.00144208.
Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176(3):285–90. https://doi.org/10.1164/rccm.200612-1792OC.
Mouronte-Roibás C, Leiro-Fernández V, Fernández-Villar A, Botana-Rial M, Ramos-Hernández C, Ruano-Ravina A. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett. 2016;382(2):240–4. https://doi.org/10.1016/j.canlet.2016.09.002.
Wang W, Dou S, Dong W, et al. Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity. Int J Chron Obstruct Pulmon Dis. 2018;13:3767–76. https://doi.org/10.2147/COPD.S168048.
Gullón JA, Suárez I, Medina A, Rubinos G, Fernández R, González I. Role of emphysema and airway obstruction in prognosis of lung cancer. Lung Cancer. 2011;71(2):182–5. https://doi.org/10.1016/j.lungcan.2010.05.018.
Dasari V, Gallup M, Lemjabbar H, Maltseva I, McNamara N. Epithelial-mesenchymal transition in lung cancer: is tobacco the “smoking gun”? Am J Respir Cell Mol Biol. 2006;35(1):3–9. https://doi.org/10.1165/rcmb.2006-0051SF.
Bruse S, Sood A, Petersen H, et al. New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than Non-Hispanic Whites. Am J Respir Crit Care Med. 2011;184(11):1254–60. https://doi.org/10.1164/rccm.201103-0568OC.
Petersen H, Sood A, Meek PM, et al. Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. Chest. 2014;145(4):695–703. https://doi.org/10.1378/chest.13-0799.
Diaz AA, Come CE, Mannino DM, et al. Obstructive lung disease in Mexican Americans and non-Hispanic whites: an analysis of diagnosis and survival in the National Health and Nutritional Examination Survey III Follow-up Study. Chest. 2014;145(2):282–9. https://doi.org/10.1378/chest.13-1414.
Powell R, Davidson D, Divers J, et al. Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study. Thorax. 2013;68(7):634–42. https://doi.org/10.1136/thoraxjnl-2012-202116.
Powell R, Barr RG. Response letter to: the Hispanic paradox further unraveled? Thorax. 2014;69(2):185–6. https://doi.org/10.1136/thoraxjnl-2013-204408.
Manichaikul A, Hoffman EA, Smolonska J, et al. Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med. 2014;189(4):408–18. https://doi.org/10.1164/rccm.201306-1061OC.
Ambrogi V, Pompeo E, Elia S, Pistolese GR, Mineo TC. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2003;23(5):811–7. https://doi.org/10.1016/s1010-7940(03)00093-9.
Kravchenko J, Berry M, Arbeev K, Lyerly HK, Yashin A, Akushevich I. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Cancer Amst Neth. 2015;88(1):85–93. https://doi.org/10.1016/j.lungcan.2015.01.006.
van’t Klooster CC, Ridker PM, Hjortnaes J, et al. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J. 2019;40(48):3901–3909. https://doi.org/10.1093/eurheartj/ehz587
Prizment AE, Folsom AR, Dreyfus J, et al. Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study. Cancer Causes Control CCC. 2013;24(12):2077–87. https://doi.org/10.1007/s10552-013-0285-y.
Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(13):2217–24. https://doi.org/10.1200/JCO.2008.19.8440.
Siemes C, Visser LE, Coebergh JWW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(33):5216–22. https://doi.org/10.1200/JCO.2006.07.1381.
Ridker PM, MacFadyen JG, Thuren T, et al. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet Lond Engl. 2017;390(10105):1833–42. https://doi.org/10.1016/S0140-6736(17)32247-X.
Herrero Rivera D, Nieto-Guerrero Gómez JM, Cacicedo Fernández de Bobadilla J, et al. Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2019;21(9):1220–1230. https://doi.org/10.1007/s12094-019-02047-5
Moik F, Zöchbauer-Müller S, Posch F, Pabinger I, Ay C. Systemic inflammation and activation of haemostasis predict poor prognosis and response to chemotherapy in patients with advanced lung cancer. Cancers. 2020;12(6):E1619. https://doi.org/10.3390/cancers12061619.
Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4):155–70. https://doi.org/10.3109/10408363.2011.599831.
Daviglus ML, Talavera GA, Avilés-Santa ML, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA J Am Med Assoc. 2012;308(17):1775–84. https://doi.org/10.1001/jama.2012.14517.
Soneji S, Tanner NT, Silvestri GA, Lathan CS, Black W. Racial and ethnic disparities in early-stage lung cancer survival. Chest. 2017;152(3):587–97. https://doi.org/10.1016/j.chest.2017.03.059.
Shiels MS, Chernyavskiy P, Anderson WF, et al. Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data. Lancet Lond Engl. 2017;389(10073):1043–54. https://doi.org/10.1016/S0140-6736(17)30187-3.
Abraído-Lanza AF, Dohrenwend BP, Ng-Mak DS, Turner JB. The Latino mortality paradox: a test of the “salmon bias” and healthy migrant hypotheses. Am J Public Health. 1999;89(10):1543–8.
Abraído-Lanza AF, Armbrister AN, Flórez KR, Aguirre AN. Toward a theory-driven model of acculturation in public health research. Am J Public Health. 2006;96(8):1342–6. https://doi.org/10.2105/AJPH.2005.064980.
Thamer M, Richard C, Casebeer AW, Ray NF. Health insurance coverage among foreign-born US residents: the impact of race, ethnicity, and length of residence. Am J Public Health. 1997;87(1):96–102. https://doi.org/10.2105/ajph.87.1.96.
Chartier KG, Carmody T, Akhtar M, Stebbins MB, Walters ST, Warden D. Hispanic subgroups, acculturation, and substance abuse treatment outcomes. J Subst Abuse Treat. 2015;59:74–82. https://doi.org/10.1016/j.jsat.2015.07.008.
Chang A, Kenya S, Ilangovan K, et al. Is greater acculturation associated with an increased prevalence of cardiovascular risk factors among Latinos in South Florida? Med Care. 2015;53(5):417–22. https://doi.org/10.1097/MLR.0000000000000337.
Caetano R, Ramisetty-Mikler S, Rodriguez LA. The Hispanic Americans Baseline Alcohol Survey (HABLAS): the association between birthplace, acculturation and alcohol abuse and dependence across Hispanic national groups. Drug Alcohol Depend. 2009;99(1–3):215–21. https://doi.org/10.1016/j.drugalcdep.2008.08.011.
Chau B, Ituarte PH, Shinde A, et al. Disparate outcomes in nonsmall cell lung cancer by immigration status. Cancer Med. 2021;10(8):2660–7. https://doi.org/10.1002/cam4.3848.
Cheung MC, Earle CC, Fischer HD, et al. Impact of immigration status on cancer outcomes in Ontario, Canada. J Oncol Pract. 2017;13(7):e602–12. https://doi.org/10.1200/JOP.2016.019497.
Strom JL, Egede LE. The impact of social support on outcomes in adult patients with type 2 diabetes: a systematic review. Curr Diab Rep. 2012;12(6):769–81. https://doi.org/10.1007/s11892-012-0317-0.
Young CF, Shubrook JH, Valencerina E, Wong S, Henry Lo SN, Dugan JA. Associations between social support and diabetes-related distress in people with type 2 diabetes mellitus. J Osteopath Med. 2020;120(11):721–31. https://doi.org/10.7556/jaoa.2020.145.
Reblin M, Uchino BN. Social and emotional support and its implication for health. Curr Opin Psychiatry. 2008;21(2):201–5. https://doi.org/10.1097/YCO.0b013e3282f3ad89.
Hofman A, Zajdel N, Klekowski J, Chabowski M. Improving social support to increase QoL in lung cancer patients. Cancer Manag Res. 2021;13:2319–27. https://doi.org/10.2147/CMAR.S278087.
Sullivan DR, Forsberg CW, Ganzini L, et al. Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer Amst Neth. 2016;100:102–9. https://doi.org/10.1016/j.lungcan.2016.08.008.
Pinquart M, Duberstein PR. Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol. 2010;75(2):122–37. https://doi.org/10.1016/j.critrevonc.2009.06.003.
Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA. 1987;258(21):3125–30. https://doi.org/10.1001/jama.1987.03400210067027.
Kravdal O. A cancer survival model that takes sociodemographic variations in “normal” mortality into account: comparison with other models. J Epidemiol Community Health. 2002;56(4):309–18. https://doi.org/10.1136/jech.56.4.309.
Losada A, Marquez-Gonzalez M, Knight BG, Yanguas J, Sayegh P, Romero-Moreno R. Psychosocial factors and caregivers’ distress: effects of familism and dysfunctional thoughts. Aging Ment Health. 2010;14(2):193–202. https://doi.org/10.1080/13607860903167838.
Gresenz CR, Rogowski J, Escarce JJ. Community demographics and access to health care among U.S. Hispanics. Health Serv Res. 2009;44(5 Pt 1):1542–62. https://doi.org/10.1111/j.1475-6773.2009.00997.x.
NW 1615 L. St, Washington S 800, inquiries D 20036 U 419 4300 | main202 419 4349 | fax202 419 4372 | media. The Shifting Religious Identity of Latinos in the United States. Pew Research Center’s Religion & Public Life Project. Published May 7, 2014. https://www.pewforum.org/2014/05/07/the-shifting-religious-identity-of-latinos-in-the-united-states/. Accessed 16 Aug 2021.
Culver JL, Arena PL, Wimberly SR, Antoni MH, Carver CS. Coping among African-American, Hispanic, and non-Hispanic White women recently treated for early stage breast cancer. Psychol Health. 2004;19(2):157–66. https://doi.org/10.1080/08870440310001652669.
Culver JL, Arena PL, Antoni MH, Carver CS. Coping and distress among women under treatment for early stage breast cancer: comparing African Americans, Hispanics and non-Hispanic Whites. Psychooncology. 2002;11(6):495–504. https://doi.org/10.1002/pon.615.
Carrion IV, Nedjat-Haiem F, Macip-Billbe M, Black R. “I Told myself to stay positive” perceptions of coping among Latinos with a cancer diagnosis living in the United States. Am J Hosp Palliat Med. 2017;34(3):233–40. https://doi.org/10.1177/1049909115625955.
Olivier M, Hollstein M, Hainaut P. TP53 Mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008. https://doi.org/10.1101/cshperspect.a001008.
Lee CS, Sharma S, Miao E, Mensah C, Sullivan K, Seetharamu N. A comprehensive review of contemporary literature for epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer and their toxicity. Lung Cancer Targets Ther. 2020;11:73–103. https://doi.org/10.2147/LCTT.S258444.
Study to Compare AMG 510 “Proposed INN sotorasib” with docetaxel in non small cell lung cancer (NSCLC) (CodeBreak 200). - Tabular View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/record/NCT04303780. Accessed 16 Aug 2021.
Steuer CE, Behera M, Berry L, et al. The role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: results from the Lung Cancer Mutation Consortium (LCMC). Cancer. 2016;122(5):766–72. https://doi.org/10.1002/cncr.29812.
Arrieta O, Campos-Parra AD, Zuloaga C, et al. Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2012;7(8):1228–34. https://doi.org/10.1097/JTO.0b013e3182582a93.
Arrieta O, Ramírez-Tirado LA, Báez-Saldaña R, Peña-Curiel O, Soca-Chafre G, Macedo-Perez EO. Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the “Hispanic paradox.” Lung Cancer. 2015;90(2):161–6. https://doi.org/10.1016/j.lungcan.2015.08.010.
Hosgood HD, Boffetta P, Greenland S, et al. In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium. Environ Health Perspect. 2010;118(12):1743–7. https://doi.org/10.1289/ehp.1002217.
Lung Cancer Screening Resources. https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources. Accessed 16 Aug 2021.
de Groot PM, Wu CC, Carter BW, Munden RF. The epidemiology of lung cancer. Transl Lung Cancer Res. 2018;7(3):220–33. https://doi.org/10.21037/tlcr.2018.05.06.
State Lung Cancer Screening Coverage Toolkit. https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/saved-by-the-scan/resources/state-lung-cancer-screening. Accessed 16 Aug 2021.
Bureau UC. Health insurance. The United States Census Bureau. https://www.census.gov/topics/health/health-insurance.html. Accessed 16 Aug 2021
Franks P, Clancy CM, Gold MR. Health insurance and mortality. Evidence from a national cohort. JAMA. 1993;270(6):737–41.
Vidaver RM, Shershneva MB, Hetzel SJ, Holden TR, Campbell TC. Typical time to treatment of patients with lung cancer in a multisite, US-based study. J Oncol Pract. 2016;12(6):e643-653. https://doi.org/10.1200/JOP.2015.009605.
Díaz AA, Celli B, Celedón JC. Chronic obstructive pulmonary disease in Hispanics. A 9-year update. Am J Respir Crit Care Med. 2018;197(1):15–21. https://doi.org/10.1164/rccm.201708-1615PP.
Schaeffer K. The most common age among Whites in U.S. is 58 – more than double that of racial and ethnic minorities. Pew Research Center. https://www.pewresearch.org/fact-tank/2019/07/30/most-common-age-among-us-racial-ethnic-groups/. Accessed 16 Aug 2021.
Granados G, Puvvula J, Berman N, Dowling PT. Health care for Latino children: impact of child and parental birthplace on insurance status and access to health services. Am J Public Health. 2001;91(11):1806–7. https://doi.org/10.2105/ajph.91.11.1806.
Lara M, Gamboa C, Kahramanian MI, Morales LS, Hayes Bautista DE. Acculturation and Latino health in the United States: a review of the literature and its sociopolitical context. Annu Rev Public Health. 2005;26:367–97. https://doi.org/10.1146/annurev.publhealth.26.021304.144615.
Funding
This study was funded in part by the Albert Einstein College of Medicine Global Health Center.
Author information
Authors and Affiliations
Contributions
Material preparation, and data collection and synthesis were performed by Emily Miao and H Dean Hosgood. The first draft of the manuscript was written by Emily Miao and all the authors commented on previous versions of the manuscript. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent to Publish
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Miao, E., Klugman, M., Rohan, T. et al. Hypothesized Explanations for the Observed Lung Cancer Survival Benefit Among Hispanics/Latinos in the United States. J. Racial and Ethnic Health Disparities 10, 1339–1348 (2023). https://doi.org/10.1007/s40615-022-01319-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40615-022-01319-1